Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients' experiences and perspectives of living with CKD.
Tong A, Sainsbury P, Chadban S, Walker RG, Harris DC, Carter SM, Hall B, Hawley C, Craig JC. Tong A, et al. Among authors: walker rg. Am J Kidney Dis. 2009 Apr;53(4):689-700. doi: 10.1053/j.ajkd.2008.10.050. Epub 2009 Feb 11. Am J Kidney Dis. 2009. PMID: 19216015
Research Priorities in CKD: Report of a National Workshop Conducted in Australia.
Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, Gallagher M, Hawley CM, Hill S, Howard K, Johnson DW, Kerr PG, McKenzie A, Parker D, Perkovic V, Polkinghorne KR, Pollock C, Strippoli GF, Tugwell P, Walker RG, Webster AC, Wong G, Craig JC. Tong A, et al. Among authors: walker rg. Am J Kidney Dis. 2015 Aug;66(2):212-22. doi: 10.1053/j.ajkd.2015.02.341. Epub 2015 May 2. Am J Kidney Dis. 2015. PMID: 25943716
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM; HERO Study Collaborative Group. Johnson DW, et al. Am J Kidney Dis. 2015 Jan;65(1):49-57. doi: 10.1053/j.ajkd.2014.06.020. Epub 2014 Aug 10. Am J Kidney Dis. 2015. PMID: 25115616 Clinical Trial.
Barriers to timely arteriovenous fistula creation: a study of providers and patients.
Lopez-Vargas PA, Craig JC, Gallagher MP, Walker RG, Snelling PL, Pedagogos E, Gray NA, Divi MD, Gillies AH, Suranyi MG, Thein H, McDonald SP, Russell C, Polkinghorne KR. Lopez-Vargas PA, et al. Among authors: walker rg. Am J Kidney Dis. 2011 Jun;57(6):873-82. doi: 10.1053/j.ajkd.2010.12.020. Epub 2011 Mar 15. Am J Kidney Dis. 2011. PMID: 21411202
Adolescent views on transition in diabetes and nephrology.
Tong A, Wong G, Hodson E, Walker RG, Tjaden L, Craig JC. Tong A, et al. Among authors: walker rg. Eur J Pediatr. 2013 Mar;172(3):293-304. doi: 10.1007/s00431-012-1725-5. Epub 2012 May 11. Eur J Pediatr. 2013. PMID: 22576804 Review.
286 results